Cognitive impairment in progressive supranuclear palsy is associated with tau burden.
Cognitive impairment in progressive supranuclear palsy is associated with tau burden.
复制标题
DOI:
10.1002/mds.27198
复制
发表时间:
2017-12
期刊:
影响因子:
--
通讯作者:
Dickson DW
中科院分区:
文献类型:
--
作者:
Koga S;Parks A;Kasanuki K;Sanchez-Contreras M;Baker MC;Josephs KA;Ahlskog JE;Uitti RJ;Graff-Radford N;van Gerpen JA;Wszolek ZK;Rademakers R;Dickson DW
Cognitive impairment is one of the core features of progressive supranuclear palsy. This study aimed to clarify the profile of cognitive impairment and its underlying pathology in progressive supranuclear palsy. We retrospectively reviewed medical records to evaluate the pattern and severity of cognitive impairment in 121 autopsy-confirmed progressive supranuclear palsy patients. A subset of 37 patients underwent neuropsychological evaluation as part of their clinical work-up. The burden of progressive supranuclear palsy-related tau pathology (neurofibrillary tangles/pretangles, coiled bodies, tufted astrocytes, and threads) was semi-quantitatively scored in 20 vulnerable brain regions. Concurrent pathologies potentially associated with cognitive impairment, such as Alzheimer-type pathology, were also assessed. To evaluate possible genetic risk factors for cognitive impairment, genetic analysis for APOE and MAPT was performed. Ninety patients (74%) had documented cognitive impairment based on neurologic evaluation. In a subgroup with neuropsychological testing (N = 37), executive functioning was the most severely impaired cognitive domain. A global cognitive impairment index (Spearman’s rho −0.49, P = 0.005) and executive functioning were negatively correlated with total tau burden (Spearman’s rho −0.51, P = 0.003), but not correlated with the Alzheimer-type pathology. APOE ε4 carriers had more severe amyloid pathology, but total tau burden and overall test battery mean was not different from APOE ε4 non-carriers. Cognitive impairment in progressive supranuclear palsy, most notably executive dysfunction, is associated with severity of progressive supranuclear palsy-related tau pathology.
登录
查看更多内容
影响因子:
9.9
作者:
Day, Gregory S.;Lim, Tae Sung;Morris, John C.
通讯作者:
Morris, John C.
影响因子:
3.3
作者:
Fiorenzato, Eleonora;Weis, Luca;Biundo, Roberta
通讯作者:
Biundo, Roberta
影响因子:
4.8
作者:
Dickson, Dennis W.;Ahmed, Zeshan;Josephs, Keith A.
通讯作者:
Josephs, Keith A.
影响因子:
0.8
作者:
Bak, TH;Crawford, LM;Hodges, JR
通讯作者:
Hodges, JR
影响因子:
14.5
作者:
Ahmed, Zeshan;Josephs, Keith A.;Dickson, Dennis W.
通讯作者:
Dickson, Dennis W.